Return to content in this issue


Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe Asthma

Sposato B1, Scalese M2, Milanese M3, Masieri S4, Cavaliere C4, Latorre M5, Scichilone N6, Matucci A7, Vultaggio A7, Ricci A8, Cresti A9, Paggiaro PL5

1Pneumology Department, Misericordia Hospital, Grosseto, Italy
2Institute of Clinical Phisiology, CNR, Pisa, Italy
3Pneumology Department, S.Corona Hospital, Pietra Ligure, Italy
4Otorhinolaryngology Clinic, Policlinico Umberto I, “Sapienza” University, Rome, Italy
5Cardio Thoracic and Vascular Department, Pathophysiology Unit, University of Pisa, Pisa, Italy
6DIMPEFINU, Unit of Pneumology and Medicine, University of Palermo, Palermo, Italy
7Immunoallergology Unit, Department of Medicine and Geriatric, AOU Careggi, Florence, Italy
8Division of Pneumology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, AOU Sant'Andrea, Rome, Italy
9Cardiology Department, Misericordia Hospital, Grosseto, Italy

J Investig Allergol Clin Immunol 2017; Vol 27(6) : 388-391
doi: 10.18176/jiaci.0196

Key words: Omalizumab, Severe asthma, Pollen sensitized, Effectiveness, Real-life